NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
INDV Indivior
- 8.260
- +0.010+0.12%
Close Feb 25 16:00 ET
- 8.210
- -0.050-0.61%
Pre 05:31 ET
1.03BMarket Cap-22.94P/E (TTM)
8.290High7.620Low2.38MVolume7.880Open8.250Pre Close19.21MTurnover2.42%Turnover RatioLossP/E (Static)124.14MShares22.53052wk High-5.00P/B810.21MFloat Cap7.33052wk Low--Dividend TTM98.09MShs Float26.500Historical High--Div YieldTTM8.12%Amplitude7.330Historical Low8.085Avg Price1Lot Size
Indivior News
Jefferies Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $12.35
Indivior PLC Sees Shift in Voting Rights With Morgan Stanley Acquisition
Express News | Indivior PLC Morgan Stanley - Holding(S) in Company
Indivior Gets FDA Approval for Faster Initiation of Opioid-Dependence Treatment, More Injection Options
Express News | FDA Approves Label Changes For Indivior's SUBLOCADE, Cutting Start Time To One Hour
Indivior's SUBLOCADE Receives FDA Approval for Rapid OUD Treatment Protocol
Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Indivior's Earnings Call: Growth Amidst Challenges
Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $15
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Indivior (GB:INDV)
Sector Update: Health Care Stocks Advance Late Afternoon
Sector Update: Health Care
Earnings Call Summary | Indivior(INDV.US) Q4 2024 Earnings Conference
Indivior Targets $1.5B Peak Revenue for Sublocade Amid 2025 Transition Plans
Indivior | 6-K/A: Report of foreign private issuer (related to financial reporting)
Indivior Price Target Lowered to 1,100 GBp From 1,400 GBp at Stifel
Top Premarket Decliners
Indivior PLC (INDV) Q4 Earnings Meet Estimates
Indivior | 6-K: Report of foreign private issuer (related to financial reporting)
Stifel Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $13.9